KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Year-over-year revenue growth rate
Latest
337.66%
↑ 490% vs avg
Percentile
P95
Near historical high
Streak
1 qtr
Consecutive declineDecelerating
Average
57.25%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 337.66% |
| Q3 2025 | 860.17% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | -100.00% |
| Q2 2020 | 142.49% |
| Q1 2020 | -59.77% |
| Q4 2019 | 16.36% |
| Q3 2019 | 15.14% |
| Q2 2019 | -24.78% |
| Q1 2019 | -30.44% |
| Q4 2018 | 50.40% |
| Q3 2018 | -23.18% |
| Q2 2018 | 107.64% |
| Q1 2018 | 106.83% |
| Q4 2017 | 1073.96% |
| Q3 2017 | -15.79% |
| Q2 2017 | -54.03% |
| Q1 2017 | 0.00% |
| Q3 2016 | -100.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -12.50% |